Records containing: Membranous Nephropathy - PLA2R Induced
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-03Analysis of T- and B-Cell Subpopulations in Patients With Primary Membranous Nephropathy
-
CLINICAL_TRIALS study record update · 2026-01-06Obinutuzumab Induced Decreases of PLA2Rab in MN: a Pilot Study
-
CLINICAL_TRIALS study record update · 2025-06-11Evaluation of the Safety and Efficacy of the BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases: A Single-center Exploratory Clinical Study
-
CLINICAL_TRIALS study record update · 2024-05-07Rituximab, Cyclophosphamide, and Corticosteroids at Low Cumulative Doses to Induce Remission in Primary Membranous Nephropathy
-
CLINICAL_TRIALS study record update · 2024-02-21Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)
- Organize your saved records without ads with Plus.